Several brokerages have updated their recommendations and price targets on shares of Incyte (NASDAQ: INCY) in the last few weeks: 4/1/2026 – Incyte was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”. 3/25/2026 – Incyte had its price target lowered by UBS Group AG from $104.00 to $94.00. They now have a “neutral” […]

Nektar Therapeutics (NASDAQ: NKTR) recently received a number of ratings updates from brokerages and research firms: 3/29/2026 – Nektar Therapeutics was downgraded by Wall Street Zen from “hold” to “sell”. 3/24/2026 – Nektar Therapeutics is now covered by Wedbush. They set a “neutral” rating and a $70.00 price target on the stock. 3/21/2026 – Nektar […]

A number of research firms have changed their ratings and price targets for First Solar (NASDAQ: FSLR): 4/7/2026 – First Solar had its price target lowered by Jefferies Financial Group Inc. from $205.00 to $187.00. They now have a “hold” rating on the stock. 3/27/2026 – First Solar had its “hold (c+)” rating reaffirmed by […]

A number of firms have modified their ratings and price targets on shares of Permian Resources (NYSE: PR) recently: 4/7/2026 – Permian Resources is now covered by KeyCorp. They set an “overweight” rating and a $25.00 price target on the stock. 3/31/2026 – Permian Resources had its price target raised by Citigroup Inc. from $21.00 […]

Apellis Pharmaceuticals (NASDAQ: APLS) recently received a number of ratings updates from brokerages and research firms: 4/2/2026 – Apellis Pharmaceuticals was downgraded by Roth Mkm from “strong-buy” to “hold”. 4/2/2026 – Apellis Pharmaceuticals had its price target raised by Mizuho from $20.00 to $41.00. They now have a “neutral” rating on the stock. 4/1/2026 – […]

Dell Technologies (NYSE: DELL) recently received a number of ratings updates from brokerages and research firms: 4/6/2026 – Dell Technologies had its price target raised by Mizuho from $180.00 to $215.00. They now have an “outperform” rating on the stock. 4/1/2026 – Dell Technologies was downgraded by Weiss Ratings from “buy (b-)” to “hold (c+)”. […]

Fair Isaac (NYSE: FICO) recently received a number of ratings updates from brokerages and research firms: 4/2/2026 – Fair Isaac had its price target lowered by The Goldman Sachs Group, Inc. from $1,770.00 to $1,528.00. They now have a “buy” rating on the stock. 3/24/2026 – Fair Isaac had its price target lowered by JPMorgan […]